•  
  •  
  •  
  •  

2025-12-23 12:36:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  GAEL

Stock Report

  • Gujarat Ambuja Exports Ltd commissions 30,000 TPA Sodium Gluconate Plant at Hubli, Karnataka
  • Gujarat Ambuja Exports Ltd commences commercial production of Greenfield 1200 TPD Maize Processing unit
  • Gujarat Ambuja Exports Ltd commissions 120 TPD Liquid Glucose Unit
  • Gujarat Ambuja Exports Ltd revises record date for 1:1 bonus issue
  • Gujarat Ambuja Exports Ltd commissions 100 TPD Sorbitol Unit
  • Gujarat Ambuja Exports Ltd becomes largest Sorbitol Manufacturer in India
  • Gujarat Ambuja Exports Ltd commissions 1200TPD Maize Processing Greenfield Project at Malda, West Bengal
  • Gujarat Ambuja Exports Ltd inks MOU with Gujarat Government for new plant
  • Gujarat Ambuja Exports Ltd recommends final dividend of Rs. 0.65
  • Gujarat Ambuja Exports to set up greenfield 1000 TPD capacity

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024